Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Inhibrx, Inc. — Inhibrx Biosciences, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Inhibrx, Inc.

Inhibrx, Inc.

10% owner at Inhibrx Biosciences, Inc. · on record since May 31, 2024
10% owner at Glori Energy Inc. · on record since May 24, 2024

Insider trading activity of Inhibrx, Inc.

Transactions on record: 1; since May 31, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 31, 2024

Figures computed from official regulatory filings — methodology.

Companies where Inhibrx, Inc. has traded

Inhibrx Biosciences, Inc.1 tx · May 31, 2024

Track record of Inhibrx, Inc.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Inhibrx, Inc.

Co-insiders of Inhibrx, Inc.

Deck KellyGlori Energy Inc. +1
Eckelman Brendan P.Glori Energy Inc. +1
FORSYTH DOUGLASGlori Energy Inc. +1
HALVORSEN OLE ANDREASGlori Energy Inc. +1
Kayyem Jon FaizGlori Energy Inc. +1
Lappe MarkGlori Energy Inc. +1
MANHARD KIMBERLYGlori Energy Inc. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Ott David C.Glori Energy Inc. +1

Shabet Rose SharonGlori Energy Inc. +1

VIKING GLOBAL INVESTORS LPGlori Energy Inc. +1

Viking Global Opportunities GP LLCGlori Energy Inc. +1

Viking Global Opportunities Illiquid Investments Sub-Master LPGlori Energy Inc. +1

Viking Global Opportunities Parent GP LLCGlori Energy Inc. +1

Viking Global Opportunities Portfolio GP LLCGlori Energy Inc. +1

Vuori Kristiina MDGlori Energy Inc. +1

Al-Zawawi Waleed Omer Abdul-MonemGlori Energy Inc.

Aschebrook Larry LeeGlori Energy Inc.

Bierhaus WilliamGlori Energy Inc.

Chess MarkGlori Energy Inc.

CLARKE JOHN UGlori Energy Inc.

Deveraux Quinn L.Inhibrx Biosciences, Inc.

DRAGSA 50 LLCInhibrx Biosciences, Inc.

Duckworth Rocky LGlori Energy Inc.

Eckelman Living Trust Dated February 5, 2014Inhibrx Biosciences, Inc.

FLEMING JONATHANGlori Energy Inc.

Friske Harry MaxwellGlori Energy Inc.

Gibbs Matthew AGlori Energy Inc.

Guilbeau KevinGlori Energy Inc.

HICKS THOMAS OGlori Energy Inc.

Holland Thomas LeeGlori Energy Inc.

Jon F. Kayyem & Paige Gates-Kayyem Family TrustInhibrx Biosciences, Inc.

KISHORE GANESHGlori Energy Inc.

Kolchinsky PeterInhibrx Biosciences, Inc.

Lappe Family TrustInhibrx Biosciences, Inc.

Malaysian Life Sciences Capital Fund Ltd.Glori Energy Inc.

Matly DavidInhibrx Biosciences, Inc.

McHugh RyanGlori Energy Inc.

mRNA Fund V LPGlori Energy Inc.

Musselman James C.Glori Energy Inc.

Neuman Eric CGlori Energy Inc.

Nimitz KennethGlori Energy Inc.

OBP Management V L.P.Glori Energy Inc.

Oxford Bioscience Partners V L.P.Glori Energy Inc.

Page Stuart MGlori Energy Inc.

Pavia MichaelGlori Energy Inc.

PEREZ VICTOR MGlori Energy Inc.

Puckett Mark BedfordGlori Energy Inc.

RA CAPITAL MANAGEMENT, LLCInhibrx Biosciences, Inc.

Rawie Damon LairdGlori Energy Inc.

Schulhof JonathanGlori Energy Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Inhibrx Biosciences, Inc.	May 31, 2024	Other	-13,316,140	—	—	SEC